Clinical Trial

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

Study acronym: LACOG 1818
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 11, 2025 (before its estimated May 7, 2025 completion). Its status may not reflect the trial's current state.
Summary
Survival outcomes in metastatic prostate cancer in the population Brazilian - analysis of individual characteristics and modalities of treatment in different national health institutions
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2021-07-06; most recent amendment 2025-02-10.
Status change: Recruiting → Active, Not Recruiting 2024-03-12
Trial Details
NCT Number NCT04962919
Lead Sponsor Latin American Cooperative Oncology Group
Conditions Prostatic Neoplasms, Castration-Resistant
Enrollment 584 participants
Start Date 2020-01-14
Primary Completion 2025-05-07 (estimated)
Study Completion 2025-05-07 (estimated)
Updated on ClinicalTrials.gov 2025-02-11